Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia - Wikidata - awgldk - TriplyDB

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

http://www.wikidata.org/entity/Q28284944

about

Mucormycosis, pseudallescheriasis, and other uncommon mold infections Therapeutic Drug Monitoring of Posaconazole: an Update Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole Infections in myelodysplastic syndromes Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French S Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysis Antifungal Prophylaxis in Immunocompromised Patients Fundament and Prerequisites for the Application of an Antifungal TDM Service Posaconazole: an oral triazole with an extended spectrum of activity Invasive aspergillosis in the intensive care unit Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model Intensive care medicine research agenda on invasive fungal infection in critically ill patients.Prophylactic Measures During Induction for Acute Myeloid Leukemia.Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus.A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.A Review of Diagnostic Methods for Invasive Fungal Diseases: Challenges and Perspectives.Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia.Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemia.Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects.Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease.Skin concentrations and pharmacokinetics of posaconazole after oral administration.Prevalence of invasive fungal disease in hematological patients at a tertiary university hospital in Singapore ERG11 Gene Mutations and MDR1 Upregulation Confer Pan-Azole Resistance in Candida tropicalis Causing Disseminated Candidiasis in an Acute Lymphoblastic Leukemia Patient on Posaconazole Prophylaxis.How we treat febrile neutropenia in patients receiving cancer chemotherapy Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study.A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives.Incidence of invasive aspergillosis following remission-induction chemotherapy for acute leukemia: a retrospective cohort study in a single Canadian tertiary care centre Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands.Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients.

P2860

Q24603297-FE78451E-F5F5-4B5D-96CE-5971DE2419C1 Q26746016-A6F79B35-5318-4018-AE18-67383F435243 Q26771180-FED6799F-55FC-4B6D-B716-265C8DB4BC1B Q26782472-FF313627-425C-4115-AFD6-4FC1BCDBE7CE Q26859275-D248CE18-169F-4253-8DC0-80F1BFF6D353 Q27009221-9A673515-749C-42A5-9186-06885ED379F7 Q27320711-F13FC253-994D-418D-8FE6-87B115B6F297 Q27336142-4826B742-1D43-4E37-B52A-2F756A6F408C Q28074168-AAC31BDD-B5F1-4853-BAD6-36F91739D50B Q28085352-951EF3BA-E2C6-4951-ADD8-FADBA1F76ADF Q28291282-97944ACD-D2BC-416E-8C1B-447B7642BA6B Q28306909-2B5AFE60-939E-4F2C-AC38-CF2E85643A7A Q28485433-EE281E1D-CDB1-4BB8-8B52-D7538E580BE7 Q28553573-9F6A894A-20A7-424A-A435-8A7B5D55208C Q30235457-FC93DE91-605D-4236-A9DF-4991E4189925 Q30235496-C7B0DB05-C002-463F-9095-02636B69A837 Q30240242-4138E686-279E-4E60-99F3-7FC8F1CF3EC9 Q30853962-C5E4C7B1-0B83-4150-A253-A9A7D1596337 Q31120454-521FD009-46F7-4C25-8AA4-743F3123EEFE Q31146944-CE6B1A6E-B2AA-4D8F-A453-986898A45731 Q33517961-CADDFE6F-D71F-4426-A565-39A17788579B Q33559111-E36C9B8D-6BF8-47D0-BE18-44F156DCF029 Q33559503-E2012853-72C9-4478-9986-74B8F4223A8A Q33605503-E08147EF-0CCB-42F6-B6E7-823E29042512 Q33732549-3881D08D-5966-4936-8F2B-35B048BD26ED Q33734101-FFD50226-469A-489E-82BA-4994CD75DFE9 Q33764269-5F1D3691-7952-4089-8915-E45ABC895A45 Q33798286-06967224-5650-4901-90A6-A5267621DC4B Q33798313-286B46C4-882F-4731-972D-E7771C2D9364 Q33826421-36565C4B-5AF3-474F-9EB8-71B96AC81292 Q33830897-1F480A15-1D38-4ED9-BC9F-27FBE272AE46 Q33843670-E38FDF5F-9B24-4B16-9F46-1BE26A16D471 Q33846201-EB019A78-302D-4EE6-98E1-E13C622175F2 Q33880412-1669CEBB-6966-4614-B2C2-802A5950F17A Q33886231-F86C2686-D580-44D0-BCE2-271E17AC0CA8 Q33913605-64C302A9-DF11-4E04-9B0E-A695686E8F1A Q33957538-04AB3DE2-D411-47CF-9CCF-1F5EBADF4F33 Q33964833-93FF7F82-AFD6-4413-8980-FB6426D8C349 Q34013416-E3ECAF0D-B893-4C7E-93C8-60B6A63F99D3 Q34151170-6F5AEB53-2C4A-435B-8845-C39BB6F96568

P2860

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

http://www.wikidata.org/entity/Q28284944

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

@ast

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

@en

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

@nl

type

label

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

@ast

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

@en

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

@nl

prefLabel

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

@ast

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

@en

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

@nl

P1433

Q28284944-34D873CC-BBDB-43E8-91E5-C359E2332B99

P1476

Q28284944-7C3B545E-104B-4844-86DF-A7D91EFB4D64

P2093

Q28284944-18B32BA7-D145-42B7-970E-2BD4085618D0

Q28284944-2AF5D593-0865-4A6A-B315-45D229E32F5A

Q28284944-3E9B8354-D5D9-4CEC-A1F2-54CD4F2DAD84

Q28284944-7CDBCB3F-D860-4144-9681-0A806146AEFC

Q28284944-7CEC2C4C-4B22-4C65-B536-CF42B8CDCD5C

Q28284944-8E705C50-35F4-4716-BEE1-4D079F445629

Q28284944-940F6B12-730F-44D9-9568-8C69C35B4141

Q28284944-9A07157D-0001-40AB-ADD3-6DE412D4CD54

Q28284944-A42DB2F8-BA75-4637-935A-6AB60C5BE48B

Q28284944-B6E61EA2-28B6-4D86-B424-404F9E40D896

P304

Q28284944-3714DB67-83CE-450F-B72D-16457A488CE6

P31

Q28284944-BA0D2705-F5F8-439C-963F-74EC4E39E458

P3181

Q28284944-EA4D3D29-8BC7-4936-AC85-DE3B6E193383

P356

Q28284944-036E1B15-295A-4BCF-922D-A9C9530FD903

P407

Q28284944-19A6E21A-AB37-467E-9589-0CA15587B3E4

P433

Q28284944-674B6D57-3ED3-4B1B-B80C-8ED3AF295F8C

P478

Q28284944-D1CCA0CF-BB58-4CD8-AEAE-CED7FADF0F10

P50

Q28284944-46310FF0-1391-46D7-897F-64F0BAF16D16

P577

Q28284944-6914F772-08D1-4181-A4C2-6C781A4E44DB

P698

Q28284944-D0656958-8553-422A-A7FF-2CDA1C5B25CD

P3181

P356

P1433

The New England Journal of Medicine

P1476

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

@en

P2093

Andrew J Ullmann

http://www.w3.org/2001/XMLSchema#string

Cathy Hardalo

http://www.w3.org/2001/XMLSchema#string

David Angulo-Gonzalez

http://www.w3.org/2001/XMLSchema#string

David Helfgott

http://www.w3.org/2001/XMLSchema#string

Dick Stockelberg

http://www.w3.org/2001/XMLSchema#string

Drew J Winston

http://www.w3.org/2001/XMLSchema#string

Jerzy Holowiecki

http://www.w3.org/2001/XMLSchema#string

Johan Maertens

http://www.w3.org/2001/XMLSchema#string

Mario Petrini

http://www.w3.org/2001/XMLSchema#string

Oliver A Cornely

http://www.w3.org/2001/XMLSchema#string

P304

348-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1304991

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA061094

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

356

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17251531

http://www.w3.org/2001/XMLSchema#string